Search Results

240 results for meyers

Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts

Bristol-Myers Squibb layoffs will see the company reduce its headcount by 6% as part of an effort to reduce expenses in 2024.

BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q1 2024

BMY stock results show that Bristol-Myers Squibb beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

PLTR Stock: Palantir Beefs Up Healthcare AI Work Through Parexel Deal

Palantir stock is slipping on Thursday even as PLTR traders learn of a new contract between the data company and Parexel.

5 Crash-Proof Stocks to Buy Immediately

We may not be headed to a full-blown crisis, but savvy investors should protect their portfolios now with these crash-proof stocks.

The Top 3 Biotech Stocks to Buy in April 2024

Learn about the top three biotech stocks to take advantage of these companies’ promising futures and pharmaceutical advances.

BMI Stock Earnings: Badger Meter Beats EPS, Beats Revenue for Q1 2024

BMI stock results show that Badger Meter beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

3 Solar Stocks That Could Be Multibaggers in the Making: April Edition

Invest in these resilient these multibagger solar stocks as they navigate through current economic headwinds towards a brighter future.

3 Oil Stocks to Buy Before the Middle East Spark

These three under-the-radar oil stocks with strong ties to the industry could deliver substantial returns as Middle East tensions escalate.

3 Undervalued Dividend Stocks to Buy Now to Beat the S&P 500

If you want to outperform the S&P 500, consider these undervalued dividend stocks for juicy yields and high total return potential.

Silicon Valley’s Next Unicorns: 3 Tech Disruptors to Buy on Weakness

These tech disruptors could eventually become multibaggers that increase 10 fold or even 100 fold over the long-term.

3 Pharma Stocks That Are Money-Printing Machines in 2024

The economy, and pharma industry, are projected to grow massively. You should invest in these top three pharma stocks.

Why Is Peraso (PRSO) Stock Up 53% Today?

Peraso stock is climbing on Tuesday after the company announced a deal for its X710 chipset that has PRSO shares seeing heavy trading.

These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?

Small-cap stocks have been the market laggards but these standouts showed how to beat even top-tier tech names at their own game.

Robotics Stocks to Watch in April: 3 Top Picks Poised for Explosive Growth

Highlighting robotics stocks to buy: iRobot in recovery, Intuitive Surgical leads with high-growth potential in surgical robots.

Wall Street Favorites: 3 Warren Buffett Stocks With Strong Buy Ratings for April 2024

If you’re wondering where to invest in a stock picker’s market, these three Warren Buffett stocks are a good place to start.

If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names

Capitalize on the biotech sector’s boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments

The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today

Vertex hopes Alpine’s drug can be tested on other conditions beyond the one entering Phase 3 trial for a kidney disease.

3 Water Stocks to Snap Up Before the Next Shortage

Xylem (XYL), American Water Works (AWK), and York Water Co (YORW) are the three best water stocks to buy before the next shortage in 2024.

Nasdaq Nightmares: 3 Stocks to Sell Before Reality Sets In

DoorDash, DexCom, and Advanced Micro Devices are three Nasdaq stocks to sell before reality sets in as exuberance may be fading.

The 3 Most Undervalued Biotech Stocks to Buy in April 2024

The most undervalued biotech stocks to buy in April are intriguing value options with mature biotech plays that boast impressive pipelines.

The Bargain Hunter’s Dream: 3 Underpriced Stocks Poised for Massive Gains

Three well-known companies stick out among the market’s complexity as excellent chances for investors looking for significant gains.

March-ing Forward With Another New Year’s Prediction

In today’s Smart Money, let’s take a closer look at how Bristol-Myers is revolutionizing drug discovery in the “Age of AI,” and what it means…

Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts

With interest rates poised to fall, acquisitions will become more numerous. Here are three potential takeover targets. 

The 3 Best Biotech Stocks to Buy in Q2 2024

Biotech can be a risky industry for investors, but we’ve done the legwork for you with these three biotech stocks for Q2.

1 – 10 of 240 results